Treatment Protocol Sample Clauses

Treatment Protocol. The Contractor shall be responsible for positively identifying all target species before they are cut or herbicide applied. Failure to do so may incur unnecessary damage done to the DISTRICT, and shall be repaired or replanted at the Contractor’s expense. Any replacement materials are subject to DISTRICT’s approval.
Treatment Protocol. The clinical pharmacist will apply nationally recognized evidence-based treatment guidelines, as well as up to date clinical research information when providing hypertension management services. The following treatment guideline(s) and resources will be utilized to help direct the treatment of patients.
Treatment Protocol. The clinical pharmacist will apply nationally recognized evidence-based treatment guidelines, as well as up to date clinical research information when providing hypertension management services. The following treatment guideline(s) and resources will be utilized to help direct the treatment of patients. 2020 American Diabetes Association Standards of Medical Care in Diabetes 2020 Consensus Statement by the Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm From those guidelines, the pharmacist will use the following guiding principles for management of diabetes mellitus. These principles are not binding, and the pharmacist may deviate from what is outlined below based on an individual patient’s clinical situation. If deviations are made, the pharmacist will document rationale in the patient chart.
Treatment Protocol. A. JBCT is an intensive, milieu-based treatment program that quickly facilitates competency through a combination of group and individual therapy. B. Group therapy is central to the restoration process, and Contractor shall provide treatment daily to Patient Inmates. Group content should include one of the four group treatment domains: competency education, understanding and management of mental illness, physical exercise, and mental/social stimulation. Many group topics can be assimilated into the groupings, e.g., mock trial, music-based competency treatment, etc. C. Contractor shall provide individual sessions per day to each Patient Inmate. Individual sessions may be used to check-in with Patient Inmates and/or discuss key legal elements of the individual’s case that may be too sensitive for group discussion. Specific competency issues can best be addressed individually, e.g., a Patient Inmate understands court proceedings but struggles to apply the knowledge to their individual case. D. Contractor’s psychiatrist shall see each Patient Inmate weekly. A psychiatric assessment is a component of the admission process, and more frequent appointments shall be available as needed. E. Together on a weekly basis, the multi-disciplinary treatment team shall review: i. Progress of all Patient Inmates admitted within 30 days, ii. At subsequent 14-day intervals thereafter, and iii. When a Patient Inmate is under consideration for discharge. The multi-disciplinary treatment team shall be responsible for providing the committing court progress reports pursuant to Penal Code section 1370 subdivision (b)(1). Therapeutic Movement Wake-up Activity Wake-up Activity Wake-up Activity JBCT Incentive Store Wellness Education Staff Member 5: Current Events Staff Member 6: Competency Education Competency Education Table Games Trivia Challenge My Life, My Choice
Treatment Protocol. A. JBCT is an intensive, milieu-based treatment program that quickly facilitates competency through a combination of group and individual therapy. B. Group therapy is central to the restoration process, and CONTRACTOR shall provide treatment daily to male Patient Inmates. Group content should include one of the four group treatment domains: competency education, understanding and management of mental illness, physical exercise, and mental/social stimulation. Many group topics can be assimilated into the groupings, e.g., mock trial, music-based competency treatment, etc. C. CONTRACTOR shall provide individual sessions per day to each male Patient Inmate. Individual sessions may be used to check-in with male Patient Inmates and/or discuss key legal elements of the individual’s case that may be too sensitive for group discussion. Specific competency issues can best be addressed individually, e.g., a Patient Inmate understands court proceedings but struggles to apply the knowledge to their individual case. D. CONTRACTOR’s psychiatrist shall see each male Patient Inmate weekly. A psychiatric assessment is a component of the admission process, and more frequent appointments shall be available as needed. E. Together on a weekly basis, the multi-disciplinary treatment team shall review: i. Progress of all male Patient Inmates admitted within 30 days, ii. At subsequent 14-day intervals thereafter, and iii. When a male Patient Inmate is under consideration for discharge. The multi-disciplinary treatment team shall be responsible for providing the committing court progress reports pursuant to Penal Code section 1370 subdivision (b)(1).
Treatment Protocol. FFF shall be responsible for obtaining a Treatment Protocol, as defined in section 1.26, under the FFF IND and in accordance with the provisions of this section 5.1.
Treatment Protocol. Omrix shall provide to FFF in a timely manner any information in Omrix's possession about the Investigational Drug that is necessary for FFF to prepare the Treatment Protocol, including without limitation technical, pre-clinical, clinical, and information regarding the Manufacturing Specifications. Omrix shall provide FFF with feedback in a timely manner on drafts of the Treatment Protocol.
Treatment Protocol. Contractor shall follow the Treatment Protocol as outlined in the DSH Diversion Program Manual. The community-based diversion program shall facilitate long- term psychiatric stabilization through a combination of group therapy, individual therapy, medication as medically necessary, intensive case management and other wrap-around supports to facilitate successful participation and transition to ongoing community-based housing and treatment post-diversion participation.
Treatment Protocol. FFF shall prepare a treatment protocol ("Treatment Protocol") in consultation with and information provided by Omrix and in accordance with 21 CFR Section 312.35(a) to use the Investigational Drug to treat patients with primary immune deficiency who are not enrolled as subjects in the Clinical Trials. FFF has been engaged in discussions with the FDA regarding the Treatment Protocol and shall continue to be responsible for negotiating the terms of the Treatment Protocol with the FDA. FFF shall prepare the Treatment Protocol in time for FFF to submit it to the FDA immediately after initiation of the Phase 2 Clinical Trial with the goal of obtaining approval during or immediately after the conclusion of the Phase 2 Clinical Trial. FFF shall be the sponsor of the Treatment Protocol and shall submit the Treatment Protocol to the FDA under the FFF IND. In addition, FFF will provide Omrix with an electronic copy of the packaging material which will be used in the Treatment Protocol consistent with all FDA requirements.
Treatment Protocol. CTTC will provide the list of Objectives and Goals, the Calmare(R) Tutorial & Study Guide, Calmare(R) Treatment Protocol and the User's Manual for the MC-5A, or equivalent Calmare(R) device. Upon successful completion the participant will be awarded a Calmare(R) Scrambler MC-5A User Certificate. CTT8K41924 SCHEDULE 12 COUNTRY/ COUNTRIES IN ASSIGNED TERRITORY ITALY MALTA CTT8K41925 SCHEDULE 13 PRICING